Autologously Humanized Mice for Immune‐Oncologic Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autologously Humanized Mice for Immune‐Oncologic Studies

Published:2020-05-29 Issue:1 Volume:89 Page:
ISSN:1934-8282
Container-title:Current Protocols in Pharmacology
language:en
Short-container-title:Current Protocols in Pharmacology

Author:

Fu Juan¹²,Kim Young J.³

Affiliation:

1. Bloomberg∼Kimmel Institute for Cancer ImmunotherapyJohns Hopkins Hospital Baltimore Maryland

2. Department of Oncology, Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University School of Medicine Baltimore Maryland

3. Department Otolaryngology – Head and Neck Surgery, Vanderbilt‐Ingram Cancer CenterVanderbilt University Medical Center Nashville Tennessee

Funder

National Science Foundation

Congressionally Directed Medical Research Programs

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpph.76

Reference32 articles.

1. Toward understanding and exploiting tumor heterogeneity

2. Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

3. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

4. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts

5. Therapeutic Combinations of Immune-Modulating Antibodies in Melanoma and Beyond

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous CD34+ stem cell humanization in head and neck cancer modeling: The translational importance of T cell maturation;Oral Oncology Reports;2023-03

2. Preclinical models in head and neck squamous cell carcinoma;British Journal of Cancer;2023-02-10

3. Humanized mouse models for immuno-oncology research;Nature Reviews Clinical Oncology;2023-01-12

4. A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cells;Clinical & Translational Immunology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3